Article ID Journal Published Year Pages File Type
2130500 Experimental Cell Research 2013 15 Pages PDF
Abstract

Most chemotherapeutics harm normal cells causing severe side effects and induce the development of resistance in cancer cells. Antimicrobial peptides (AMPs), recognized as anti-cancer agents, may overcome these limitations. The most studied mechanism underlying multi-drug resistance (MDR) is the over-expression of cell membrane transporter P-glycoprotein (P-gp), which extrudes a variety of hydrophobic drugs. Additionally, P-gp contributes to cell membrane composition and increases the net negative charge on cell surface. We postulated that NK-lysin derived cationic peptide NK-2 might discriminate and preferentially eliminate P-gp over-expressing cancer cells. To test this hypothesis, we employed MDR non-small cell lung carcinoma (NCI-H460/R) and colorectal carcinoma (DLD1-TxR) cell lines with high P-gp expression. MDR cancer cells that survived NK-2 treatment had decreased P-gp expression and were more susceptible to doxorubicin. We found that NK-2 more readily eliminated P-gp high-expressing cells. Acting in ‘carpet-like’ manner NK-2 co-localized with P-gp on the MDR cancer cell membrane. The inhibition of P-gp reduced the NK-2 effect in MDR cancer cells and, vice versa, NK-2 decreased P-gp transport activity. In conclusion, NK-2 could modulate MDR in unique way, eliminating the P-gp high-expressing cells from heterogeneous cancers and making them more vulnerable to classical drug treatment.

Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (242 K)Download as PowerPoint slideHighlights► P-glycoprotein over-expression is the major cause of multi-drug resistance. ► P-glycoprotein contributes to the negative charge of the outer membrane leaflet. ► Antimicrobial cationic peptide NK-2 discriminates cancer from normal cells. ► NK-2 more readily kills P-glycoprotein expressing negatively charged cancer cells. ► Modulation of multi-drug resistance could be achieved through NK-2 action.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , , ,